• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在麻醉大鼠中,喹哌嗪的心血管效应是由外周5-羟色胺2型和5-羟色胺3型受体介导的。

The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.

作者信息

Vayssettes-Courchay C, Bouysset F, Verbeuren T J, Laubie M, Schmitt H

机构信息

Institut de Recherches Servier, Suresnes, France.

出版信息

Eur J Pharmacol. 1990 Aug 2;184(1):75-85. doi: 10.1016/0014-2999(90)90668-v.

DOI:10.1016/0014-2999(90)90668-v
PMID:2120077
Abstract

Quipazine (0.5-2 mg/kg i.v.) produced transient hypotension and bradycardia followed by sustained hypertension and variable effects on heart rate in anaesthetized rats. The hypotension, bradycardia and sympatho-inhibitory effects of quipazine were attenuated by bivagotomy. In bivagotomized rats, the hypertension produced by quipazine was not modified by hexamethonium or prazosin but was abolished by ritanserin (1 mg/kg i.v.). In ritanserin-treated rats, section of the carotid sinus nerves and vagus nerves or ICS 205.930 (0.1 mg/kg i.v.) abolished the hypotensive, bradycardic and sympatho-inhibitory effects of quipazine; the action of quipazine was not reproducible in these rats. Quipazine also inhibited the Bezold-Jarish reflex elicited by 5-HT (20 micrograms/kg i.v.). In ICS 205.930-treated rats, the hypertension evoked by quipazine was associated with a reduction in splanchnic nerve activity due to stimulation of baroreceptors. The renin-angiotensin system is not involved in the hypertensive response. The increase in heart rate produced by quipazine in bivagotomized rats was reduced by ritanserin and tertatolol (0.1 mg/kg i.v.) and abolished by a combination of both drugs. We conclude that the bradycardic and sympatho-inhibitory effects of quipazine result from activation of 5-HT3 receptors located in the cardiopulmonary area and of carotid body chemoreceptors. The hypertension and tachycardia are mediated by vascular and myocardial 5-HT2 receptors. No evidence was obtained for a central sympatho-excitatory effect.

摘要

喹哌嗪(静脉注射0.5 - 2毫克/千克)可使麻醉大鼠出现短暂性低血压和心动过缓,随后出现持续性高血压,并对心率产生不同影响。喹哌嗪的低血压、心动过缓和交感神经抑制作用可被双侧迷走神经切断术减弱。在双侧迷走神经切断的大鼠中,喹哌嗪引起的高血压不受六甲铵或哌唑嗪的影响,但可被利坦色林(静脉注射1毫克/千克)消除。在利坦色林处理的大鼠中,切断颈动脉窦神经和迷走神经或注射ICS 205.930(静脉注射0.1毫克/千克)可消除喹哌嗪的降压、心动过缓和交感神经抑制作用;喹哌嗪在这些大鼠中不再产生作用。喹哌嗪还可抑制5 - 羟色胺(静脉注射20微克/千克)引发的贝佐尔德 - 雅里什反射。在ICS 205.930处理的大鼠中,喹哌嗪引起的高血压与由于压力感受器刺激导致的内脏神经活动减少有关。肾素 - 血管紧张素系统不参与高血压反应。喹哌嗪在双侧迷走神经切断的大鼠中引起的心率增加可被利坦色林和特他洛尔(静脉注射0.1毫克/千克)降低,并被两种药物联合使用所消除。我们得出结论,喹哌嗪的心动过缓和交感神经抑制作用是由位于心肺区域的5 - HT3受体和颈动脉体化学感受器的激活引起的。高血压和心动过速由血管和心肌的5 - HT2受体介导。未获得中枢交感神经兴奋作用的证据。

相似文献

1
The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.在麻醉大鼠中,喹哌嗪的心血管效应是由外周5-羟色胺2型和5-羟色胺3型受体介导的。
Eur J Pharmacol. 1990 Aug 2;184(1):75-85. doi: 10.1016/0014-2999(90)90668-v.
2
Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area.喹哌嗪诱导麻醉猫高血压是由中枢和外周5-羟色胺2受体介导的:腹外侧加压区的作用
Eur J Pharmacol. 1991 Jan 17;192(3):389-95. doi: 10.1016/0014-2999(91)90230-n.
3
Cardiovascular effects of microinjections of quipazine into nuclei of the medulla oblongata in anaesthetized cats: comparison with L-glutamate.向麻醉猫延髓核微量注射喹哌嗪的心血管效应:与L-谷氨酸的比较。
Eur J Pharmacol. 1992 Feb 11;211(2):243-50. doi: 10.1016/0014-2999(92)90535-c.
4
The central sympatho-inhibitory effect of 5,6-dihydroxy-2-dimethylaminotetralin (M7) is mediated by alpha 2-adrenoceptors.5,6-二羟基-2-二甲基氨基四氢萘(M7)的中枢交感神经抑制作用是由α2-肾上腺素能受体介导的。
Eur J Pharmacol. 1997 Feb 12;320(2-3):151-9. doi: 10.1016/s0014-2999(96)00897-7.
5
Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.5-羟色胺引起的心血管反应:关于相关受体/机制及治疗意义的药理学最新进展
Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):45-63. doi: 10.1007/s00210-007-0179-1. Epub 2007 Aug 17.
6
Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.喹哌嗪对5-羟色胺2(5-HT2)受体的激活作用可使清醒大鼠的动脉血压升高并促进肾素分泌。
J Pharmacol Exp Ther. 1987 Dec;243(3):829-33.
7
A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.不同α2-肾上腺素能受体拮抗剂对可乐定中枢交感神经抑制作用的逆转的比较研究。
Br J Pharmacol. 1996 Feb;117(3):587-593. doi: 10.1111/j.1476-5381.1996.tb15231.x.
8
Quipazine increases renin release by a peripheral hemodynamic mechanism.喹哌嗪通过外周血流动力学机制增加肾素释放。
J Cardiovasc Pharmacol. 1990 Jan;15(1):1-9. doi: 10.1097/00005344-199001000-00001.
9
Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.迷走神经传入介导的静脉注射血清素对大鼠伤害性反射的抑制作用。II. 5-羟色胺受体亚型的作用。
Brain Res. 1992 Jul 10;585(1-2):71-86. doi: 10.1016/0006-8993(92)91192-h.
10
A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.一项针对小鼠和大鼠的行为学与生物化学研究,涉及5-HT1和5-HT2受体的假定选择性激动剂和拮抗剂。
Br J Pharmacol. 1985 Mar;84(3):743-53. doi: 10.1111/j.1476-5381.1985.tb16157.x.

引用本文的文献

1
Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats.中枢5-HT2B以及5-HT2A受体在麻醉大鼠心血管调节中作用的证据。
Br J Pharmacol. 1999 Oct;128(3):530-42. doi: 10.1038/sj.bjp.0702822.
2
A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.不同α2-肾上腺素能受体拮抗剂对可乐定中枢交感神经抑制作用的逆转的比较研究。
Br J Pharmacol. 1996 Feb;117(3):587-593. doi: 10.1111/j.1476-5381.1996.tb15231.x.
3
The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
三氯乙醇与小鼠重组5-羟色胺3受体的相互作用。
Br J Pharmacol. 1995 Apr;114(8):1641-51. doi: 10.1111/j.1476-5381.1995.tb14952.x.